Francisco David 4/A
4/A · Organogenesis Holdings Inc. · Filed Mar 3, 2026
Insider Transaction Report
Form 4/AAmended
Francisco David
Chief Financial Officer
Transactions
- Award
Class A Common Stock
[F1]2026-02-18+44,040→ 745,999 total - Tax Payment
Class A Common Stock
[F1]2026-02-18$3.84/sh−14,687$56,398→ 731,312 total
Footnotes (1)
- [F1]This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing.
Signature
/s/ William R. Kolb, Attorney-in-Fact|2026-03-03